Hepatitis C Treatment - An American study suggests depression may affect outcome.

Posted: 21-Jan-2005 << BACK

A study by researchers at Emory University School of Medicine, USA observed that patients who develop depressive symptoms during interferon-alpha/ribavirin therapy were significantly less likely to have cleared the hepatitis c virus from their blood following six months of treatment. To read the full article click here For link to relevant page on Emory University research site click here